HORMONE THERAPY IN ADVANCED BREAST-CANCER - COMPARISON BETWEEN HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MAP) AND TAMOXIFEN (TMX)

被引：0

作者：

PANNUTI, F ^{[1
]}

MARTONI, A ^{[1
]}

FRUET, F ^{[1
]}

CRICCA, A ^{[1
]}

机构：

[1] MALPIGHI HOSP,BOLOGNA,ITALY

来源：

CANCER TREATMENT REPORTS | 1979年 / 63卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1219 / 1219

页数：1

共 50 条

[41] CYCLIC AND SEQUENTIAL THERAPY WITH TAMOXIFEN AND MEDROXYPROGESTERONE ACETATE IN METASTATIC BREAST-CANCER
NEMOTO, T
PATEL, JK
ROSNER, D
DAO, TL
HALVORSON, H
JOURNAL OF SURGICAL ONCOLOGY, 1989, 41 (04) : 226 - 229
[42] HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS OOPHORECTOMY AS 1ST-LINE THERAPY OF ADVANCED BREAST-CANCER IN PREMENOPAUSAL PATIENTS
MARTONI, A
LONGHI, A
CANOVA, N
PANNUTI, F
ONCOLOGY, 1991, 48 (01) : 1 - 6
[43] EFFECT OF TAMOXIFEN AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) ON CELL-MEDIATED IMMUNE FUNCTIONS IN BREAST-CANCER PATIENTS
MALLMANN, P
DIETRICH, K
KREBS, D
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1990, 12 (10): : 699 - 706
[44] HIGH-DOSE VERSUS LOW-DOSE ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL
GALLAGHER, CJ
MCKINNA, JA
CAIRNDUFF, F
SMITH, IE
BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 213 - 213
[45] SURGICAL ADJUVANT HORMONAL-THERAPY WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MAP) IN BREAST-CANCER - RESULTS 36 MONTHS AFTER MASTECTOMY
PANNUTI, F
MARTONI, A
FRUET, F
DIMARCO, AR
PIANA, E
SACCANJOTTI, G
MANFREDI, D
MATTIOLI, G
BARBANTI, F
BATTELLI, T
FRANCHINI, A
MARRANO, D
LUNGAROTTI, F
BERGNACH, A
PANMINERVA MEDICA, 1982, 24 (03) : 187 - 194
[46] PHASE-II STUDY OF TAMOXIFEN AND HIGH-DOSE RETINYL ACETATE IN PATIENTS WITH ADVANCED BREAST-CANCER
BOCCARDO, F
CANOBBIO, L
RESASCO, M
DECENSI, AU
PASTORINO, G
BREMA, F
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (05) : 503 - 506
[47] HIGH-DOSE RETINIL ACETATE (RA) AND TAMOXIFEN (TAM) IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS (PTS)
CANOBBIO, L
REPETTO, L
PASTORINO, G
BREMA, F
OLGIATI, A
BOCCARDO, F
BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 111 - 111
[48] PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR THE TREATMENT OF METASTATIC BREAST-CANCER WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE
BLOSSEY, HC
WANDER, HE
KOEBBERLING, J
NAGEL, GA
CANCER, 1984, 54 (06) : 1208 - 1215
[49] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER - CLINICAL AND PHARMACOKINETIC STUDY WITH A COMBINED ORAL AND INTRAMUSCULAR REGIMEN
BECHER, R
MILLER, AA
HOFFKEN, K
GERHOLD, U
HIRCHE, H
SCHMIDT, CG
CANCER, 1989, 63 (10) : 1938 - 1943
[50] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN HEAVILY PRETREATED PATIENTS WITH METASTATIC BREAST-CANCER
GOSS, PE
ASHLEY, S
POWLES, TJ
COOMBES, RC
CANCER TREATMENT REPORTS, 1986, 70 (06): : 777 - 779

← 1 2 3 4 5 →